Skip to main content
OpenTrials

Clinical trial condition

Ovarian Neoplasms

Explore clinical trials studying Ovarian Neoplasms. Study availability and eligibility vary by location and protocol.

2,291 public trials 503 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Neoplasms trial results

Recruiting

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

NCT07360314

Conditions
Adnexal Diseases, Advanced Solid Tumors, Breast Diseases, +29 more
Locations
  • Yale University - Yale University School of Medicine New Haven, Connecticut, United States
  • Carolina BioOncology Institute, LLC - Cancer Therapy and Research Center Huntersville, North Carolina, United States
  • NEXT Houston Galveston, Texas, United States
  • NEXT Oncology - PARENT San Antonio, Texas, United States
View Trial Details
Recruiting

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

NCT06906341

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +25 more
Locations
  • 004 Birmingham, Alabama, United States
  • 150 Palo Alto, California, United States
  • 014 San Francisco, California, United States
  • 544 Fort Myers, Florida, United States
View all 49 locations
View Trial Details
Recruiting

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

NCT06915025

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +22 more
Locations
  • Advent Health Orlando, Florida, United States
  • Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States
  • Washington University School of Medicine in St. Louis St Louis, Missouri, United States
  • Providence Cancer Institute Portland, Oregon, United States
View Trial Details
Recruiting

Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy

NCT07225270

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
Locations
  • Mt. Sinai Comprehensive Cancer Center Miami, Florida, United States
  • Sarasota Memorial Health Care System Sarasota, Florida, United States
  • Miami Valley Hospital South Centerville, Ohio, United States
  • Zangmeister Cancer Center Columbus, Ohio, United States
View all 16 locations
View Trial Details
Recruiting

A Study to Investigate Mocertatug Rezetecan Compared With Standard of Care in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)

NCT07286266

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations
  • GSK Investigational Site Randwick, New South Wales, Australia
  • GSK Investigational Site Montreal, Quebec, Canada
  • GSK Investigational Site Montreal, Quebec, Canada
  • GSK Investigational Site Hyōgo, Japan
View Trial Details

Related conditions